Amino acid therapy to protect kidneys after heart surgery in children
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing whether giving amino acids after heart surgery can help prevent kidney injury in children at high risk. If it works, it could offer a simple way to protect kidney function during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or younger
- Weigh at least 5 kilograms (about 11 pounds)
- Be expected to have a high risk of kidney injury after heart surgery based on age, surgery type, and bypass time
- Not have chronic kidney disease or certain metabolic disorders
- Not be a preterm infant under 6 months old who was born before 36 weeks
- Not be currently on a breathing or heart machine before surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving amino acids (the building blocks of protein) through an IV during heart surgery can help protect your kidneys. It is for people having planned heart surgery and staying in the ICU afterward.
This study tests whether giving amino acids (protein building blocks) during heart surgery can help protect your kidneys from damage. If you are having heart surgery and are at high risk, this treatment might reduce the chance of kidney problems afterward.
This trial tests whether giving a special amino acid infusion (protein building blocks) through an IV can help protect kidney function in patients on ECMO, a machine that supports the heart and lungs. It is a pilot study to see if this treatment is safe and feasible in the intensive care unit.
This study tests whether giving the amino acid L-arginine soon after heart surgery can help prevent acute kidney injury (a sudden drop in kidney function). If you're recovering in the ICU after heart surgery, this may help protect your kidneys.
This Phase 2 trial tests an LSALT peptide given around the time of “on-pump” heart surgery to help prevent or reduce acute kidney injury (a sudden drop in kidney function). It may help people who are at higher risk for kidney injury during or after surgery.
This trial tests whether adding amino acid supplements during dialysis helps people with kidney failure. It may be an option if your doctor decides you need these supplements.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.